4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001179110-20-010602
Director sold 27,000 shares at an average $51.54 ($1,391,544)
- Director acquired 27,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
SOUTHWELL DAVID P · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-16 | Exercise or conversion : show line 1 in the form | +15,000 | $10.85 | $162,750 | 16,650 | D |
| 2020-10-16 | Sale : show line 2 in the form | −14,300 | $51.50 | $736,493 | 2,350 | D |
| 2020-10-16 | Sale : show line 3 in the form | −700 | $52.18 | $36,528 | 1,650 | D |
| 2020-10-16 | Exercise or conversion : show line 4 in the form | +12,000 | $11.23 | $134,760 | 13,650 | D |
| 2020-10-16 | Sale : show line 5 in the form | −11,500 | $51.52 | $592,434 | 2,150 | D |
| 2020-10-16 | Sale : show line 6 in the form | −500 | $52.18 | $26,089 | 1,650 | D |
| Open-market sales · 27,000 sh · avg $51.54 · $1,391,544 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2020-10-16 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −15,000 | $10.85 | $162,750 | $10.85 | 2023-05-15 | 15,000 | 0 | D |
| 2020-10-16 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −12,000 | $11.23 | $134,760 | $11.23 | 2027-01-02 | 12,000 | 0 | D |
Loading xslF345X03/edgar.xml…